Alzheimer's Disease and Immunotherapy

被引：0

作者：

Madeo, Jennifer ^{[1
]}

Frieri, Marianne ^{[1
]}

机构：

[1] Nassau Univ, Med Ctr, Dept Med, E Meadow, NY 11554 USA

来源：

AGING AND DISEASE | 2013年 / 4卷 / 04期

关键词：

Alzheimer's disease; immunotherapy; immunosenescence; vaccination; monoclonal antibodies; AMYLOID-BETA IMMUNOTHERAPY; CENTRAL-NERVOUS-SYSTEM; A-BETA; COGNITIVE IMPAIRMENT; MOUSE MODEL; PASSIVE IMMUNOTHERAPY; TRANSGENIC MOUSE; CLINICAL-TRIALS; DOUBLE-BLIND; MEMORY LOSS;

D O I：

暂无

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

Alzheimer's disease (AD) is a growing health care epidemic. It is the most common cause of dementia and its incidence is rising. Age, which influences the oxidative and inflammatory states of the brain, is the most important risk factor. Currently there is no disease modifying treatments available for this irreversible, progressive debilitating disease. Immunotherapy represents an emerging, potentially disease modifying strategy aimed at reducing the pathological lesions of AD and facilitating cognitive improvement. Many clinical trials are currently underway. This literature review highlights current knowledge regarding the physiology of aging and how it relates to the pathogenesis of AD. In addition, immunotherapy is discussed in the context of its mechanism, current studies and future goals.

引用

页码：210 / 220

页数：11

共 89 条

[81] The immune system, amyloid-β peptide, and Alzheimer's disease [J].

Weksler, ME ;

Gouras, G ;

Relkin, NR ;

Szabo, P .

IMMUNOLOGICAL REVIEWS, 2005, 205 :244-256

[82] Passive immunotherapy against Aβ in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage [J].

Wilcock, Donna M. ;

Rojiani, Amyn ;

Rosenthal, Arnon ;

Subbarao, Sangeetha ;

Freeman, Melissa J. ;

Gordon, Marcia N. ;

Morgan, Dave .

JOURNAL OF NEUROINFLAMMATION, 2004, 1 (1)

[83] Diverse inflammatory responses in transgenic mouse models of Alzheimer's disease and the effect of immunotherapy on these responses [J].

Wilcock, Donna M. ;

Zhao, Qun ;

Morgan, Dave ;

Gordon, Marcia N. ;

Everhart, Angela ;

Wilson, Joan G. ;

Lee, Jennifer E. ;

Colton, Carol A. .

ASN NEURO, 2011, 3 (05) :249-258

[84]

Wilcock DM, 2008, J ALZHEIMERS DIS, V15, P555

[85] Deglycosylated anti-amyloid-β antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice [J].

Wilcock, Donna M. ;

Alamed, Jennifer ;

Gottschall, Paul E. ;

Grimm, Jan ;

Rosenthal, Arnon ;

Pons, Jaume ;

Ronan, Victoria ;

Symmonds, Keisha ;

Gordon, Marcia N. ;

Morgan, Dave .

JOURNAL OF NEUROSCIENCE, 2006, 26 (20) :5340-5346

[86] Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study [J].

Winblad, Bengt ;

Andreasen, Niels ;

Minthon, Lennart ;

Floesser, Annette ;

Imbert, Georges ;

Dumortier, Thomas ;

Maguire, R. Paul ;

Blennow, Kaj ;

Lundmark, Joens ;

Staufenbiel, Matthias ;

Orgogozo, Jean-Marc ;

Graf, Ana .

LANCET NEUROLOGY, 2012, 11 (07) :597-604

[87] Murine models of Alzheimer's disease and their use in developing immunotherapies [J].

Wisniewski, Thomas ;

Sigurdsson, Einar M. .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2010, 1802 (10) :847-859

[88] An age-related decline in interleukin-10 may contribute to the increased expression of interleukin-6 in brain of aged mice [J].

Ye, SM ;

Johnson, RW .

NEUROIMMUNOMODULATION, 2001, 9 (04) :183-192

[89] Pro- and anti-inflammatory cytokines expression in rat's brain and spleen exposed to chronic mild stress: Involvement in depression [J].

You, Zili ;

Luo, Chunmei ;

Zhang, Wenzheng ;

Chen, Yubo ;

He, Jiajia ;

Zhao, Qiuying ;

Zuo, Rui ;

Wu, Yanghua .

BEHAVIOURAL BRAIN RESEARCH, 2011, 225 (01) :135-141

← 1 2 3 4 5 6 7 8 9 →